Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy
The novel strain of coronavirus that appeared in 2019, SARS-CoV-2, is the causative agent of severe respiratory disease, COVID-19, and the ongoing pandemic. As for SARS-CoV that caused the SARS 2003 epidemic, the receptor on host cells that promotes uptake, through attachment of the spike (S) protei...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Portland Press
2020
|
| Subjects: | |
| Online Access: | https://repository.londonmet.ac.uk/5831/1/cs-134-cs20200623.pdf |